SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support
Largest-ever grant from RIGHT Foundation to accelerate Phase 1b clinical trial of RSV preventive antibody Technology licensed from Gates MRI; early studies confirm suppression of RSV infection Targeting global markets while addressing unmet needs in...